A framework for living evidence synthesis in cancer: Living, interactive network meta-analysis for first-line treatment of metastatic renal cell carcinoma (mRCC).
Riaz I, He H, Ryu A, Siddiqi R, Naqvi S, Yao Y, Husnain M, Maheswari D, Sipra Q, Montori V, Joseph R, Liu H, Wang Z, Herasevich V, Singh P, Ho T, Bryce A, Pagliaro L, Murad M, Costello B. A framework for living evidence synthesis in cancer: Living, interactive network meta-analysis for first-line treatment of metastatic renal cell carcinoma (mRCC). Journal Of Clinical Oncology 2021, 39: 335-335. DOI: 10.1200/jco.2021.39.6_suppl.335.Peer-Reviewed Original ResearchInteractive tableArtificial intelligenceJavaScript programming languageFive-layered architectureMetastatic renal cell carcinomaFirst-line metastatic renal cell carcinomaLine Metastatic Renal Cell CarcinomaProgramming languageProgression-free survivalDifferent teamsComplete responseOverall survivalSystematic reviewSearch strategyDynamic featuresNetworkEvidence synthesisInteractive networkFirst-line treatmentEvidence mapRenal cell carcinomaFrameworkShared-decision makingOverall responseBaseline characteristics